Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FWUWA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,886
Award facts
- Contract value 100% obligated
- $13,886.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $13,886 by the Defense Logistics Agency (DLA) on August 28, 2025, with an ultimate completion date of September 19, 2025. The delivery order, issued without a set-aside designation, covers the supply of Nexplanon 68 mg implants, a subdermal contraceptive device. The award was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 million single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities.
This delivery order reflects DMS Pharmaceutical Group's established position as a key supplier within the federal pharmaceutical supply chain. The company leverages its woman-owned small business status to compete effectively in federal procurement markets while maintaining a robust portfolio of pharmaceutical product deliveries to military and federal healthcare systems. As a registered SAM.gov vendor since 2001, DMS Pharmaceutical Group continues to support the DoD's medical supply requirements through the DLA's systematic procurement of branded and generic prescription drugs, biologics, medical consumables, and specialty pharmaceutical products distributed to military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FWUWA?
SPE2DB25FWUWA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FWUWA worth?
The government has obligated $13,886 on SPE2DB25FWUWA.
Is contract SPE2DB25FWUWA an order under another contract?
Yes. SPE2DB25FWUWA is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUWA competed?
The extent of competition for SPE2DB25FWUWA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award